Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

PG110

Single, slow intravenous infusion

BIOLOGICAL

Placebo

Single, slow intravenous infusion that matches PG110 in appearance

Trial Locations (1)

3584 CJ

Site Ref # / Investigator 51568, Utrecht

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY